Showing results (771-780 of 2,890) with videos related to

Sort By:
Pageof 289
JACC. Cardiovascular Interventions|May 26, 2009
One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study)Nabil Dib, Jonathan Dinsmore, Zaki Lababidi, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events)Caroline Medi, Gilles Montalescot, Andrzej Budaj, et al.
JACC. Cardiovascular Interventions|May 26, 2009
In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registryFaisal Latif, Neal S Kleiman, David J Cohen, et al.
JACC. Cardiovascular Interventions|May 26, 2009
A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experienceSimon R Dixon, José P S Henriques, Laura Mauri, et al.
JACC. Cardiovascular Interventions|May 26, 2009
A longitudinal assessment of coronary interventional program quality: a report from the American College of Cardiology-National Cardiovascular Data RegistryLloyd W Klein, Paul Kolm, Xin Xu, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shockHan S Lim, Omar Farouque, Nick Andrianopoulos, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Refining the approach to renal artery revascularizationRobert D Safian, Ryan D Madder
JACC. Cardiovascular Interventions|May 26, 2009
First-in-man 1-year clinical outcomes of the Catania Coronary Stent System with Nanothin Polyzene-F in de novo native coronary artery lesions: the ATLANTA (Assessment of The LAtest Non-Thrombogenic Angioplasty stent) trialCorrado Tamburino, Alessio La Manna, Maria Elena Di Salvo, et al.
JACC. Cardiovascular Interventions|May 26, 2009
The GENESIS (Randomized, Multicenter Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent System in Patients with De Novo Lesions of the Native Coronary Arteries) trialStefan Verheye, Pierfrancesco Agostoni, Keith D Dawkins, et al.
JACC. Cardiovascular Interventions|May 26, 2009
3-year comparison of drug-eluting versus bare-metal stentsRobert J Applegate, Matthew T Sacrinty, Michael A Kutcher, et al.
Pageof 289